Interestingly, in APP/PS1/NLRP3−/− mice, M2 phenotype microglia are the majority, indicating that the NLRP3-Caspase-1 axis plays a vital role in the pathological process of AD, and this axis may be a potential therapeutic target through suppressing neuroinflammation. Here, NLRP3 is linked to Alzheimer disease.